Poxel S.A. (EPA:POXEL)
0.2430
-0.0070 (-2.80%)
At close: Mar 13, 2026
Poxel Market Cap
Poxel has a market cap or net worth of €13.06 million as of March 13, 2026. Its market cap has increased by 24.37% in one year.
Market Cap
13.06M
Enterprise Value
73.01M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.24
Market Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 193.09M to 13.06M, a decrease of -93.24%. That is a compound annual growth rate of -21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 13.06M | 3.85% |
| Dec 31, 2025 | 12.57M | 69.26% |
| Dec 31, 2024 | 7.43M | -61.80% |
| Dec 29, 2023 | 19.45M | -28.41% |
| Dec 30, 2022 | 27.16M | -80.72% |
| Dec 31, 2021 | 140.90M | -22.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermentalg | 36.47M |
| Advicenne | 26.64M |
| genOway Société anonyme | 22.31M |
| GenSight Biologics | 19.18M |
| Aelis Farma | 17.67M |
| NFL Biosciences | 14.07M |
| Oncodesign Precision Medicine Société anonyme | 9.60M |
| Plant Advanced Technologies | 7.56M |